Caliber Imaging & Diagnostics LCDX · USD

Its shares trade under the ticker LCDX. It has been listed since 27 February 2012. In the fiscal year to 31 December 2013, it reported revenue of $3.3m and a net loss of $5.5m. At that date it held total assets of $2.4m and shareholders' equity of −$12.5m.

Caliber Imaging & Diagnostics, Inc. operates as a medical technologies company that designs, develops, and markets imaging solutions that shows tissue at the cellular level. The company is headquartered in Andover, Massachusetts. The company went IPO on 2012-02-27. The firm is engaged in manufacturing of in-vivo reflectance confocal microscope and ex-vivo confocal imaging equipment for the medical device, clinical research and life science industries. The Company’s products include clinical and research. Its clinical products include VivaScope 1500, VivaScope 2500, VivaScope 3000, VivaNet and VivaScan. The Company’s research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 is reflectance confocal imaging system used to capture confocal images that depict cellular structures of living tissue, without the need for lengthy preparation protocols. The VivaScope 2500 is a confocal microscope specially designed for imaging fresh, needle aspirated, or fixed specimens in reflectance (phase contrast) mode or in fluorescence mode for specimens stained with fluorochromes.

Figures and description from our data supplier, not checked against the company's own report.

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.